MAPMI Extended-Spectrum Pathogenic Microorganism mNGS Detection CapitalBio

Features of MAPMI Extended-Spectrum Pathogenic Microorganism mNGS Detection

1. Detection of 16109 viruses, 13362 bacteria, 1659 fungi, 270 parasites, and 2500 drug resistance genes

2. 

3. Target population

• Patients who fall into this category have been identified as immunosuppressed hosts, patients with underlying disorders, and patients with severe infections who have been hospitalized multiple times.

• Patients who repeatedly fail standard microbiological tests and have subpar therapy responses

• Patients who are clinically suspected of harboring emerging diseases and who show signs of becoming infectious

• Individuals who may be infected with a certain virus

• Patients with additional clinical signs and prolonged fever and/or infection of unknown etiology

• MAPMI Test is also available in CapitalBio Medical Lab